Reach Us +441202068036
Dr. Kenneth Blum | OMICS International
ISSN: 2167-0277

Journal of Sleep Disorders & Therapy
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Dr. Kenneth Blum

Department of Addiction Research & Therapy, Malibu Beach Recovery Center, USA


Dr. Kenneth Blum (born August 8, 1939) is a researcher on neuropsychopharmacology and genetics. Dr. Kenneth Blum is known from his study on the genetics of alcoholism published in the Journal of the American Medical Association in 1990. Dr. Kenneth Blum works in the fields of neuropsychiatry and genetics, nutritional genetics, and pharmacogenetics. Blum's research has been recognized through numerous awards. Dr. Blum is currently an adjunct full professor in the Department of Psychiatry, University of Florida College of Medicine, and Mcknight Brain Institute (Gainesville, Florida), and formerly of the Department of Physiology & Pharmacology at Wake Forest University School of Medicine (Winston-Salem, North Carolina). Until 2008 he was also Chief Scientific Officer of Salugen, Inc., a personalized health and wellness company in San Diego, California. In 1995 Dr. Kenneth Blum retired as a full professor in the Department of Pharmacology, University of Texas, where he was also chief of the Division of Addictive Diseases, chief of the Division of Substance and Alcohol Misuse, and director of the Laboratory of Pharmacogenetics at the University of Texas Health Science Center (San Antonio, Texas). Currently Dr. Kenneth Blum is the Chairman of the Board and Chief Scientific Officer of LifeGen Inc. (San Diego, California), a neutrigenomic evidence-based corporation.

Research Interest

Dr. Kenneth Blum's research interest includes genetics of alcoholism, neuropsychiatry and genetics, nutritional genetics, and pharmacogenetics.

Global Speakers in the subject

Global Experts in the subject